MindImmune Therapeutics, Inc.

New Filing
CIK: 0001792522·Pharmaceuticals·DELAWARE·Filed: Dec 5, 2025
Total Offering

$12,000,000

Amount Sold

$10,203,858

Investors

14

First Sale

Nov 24, 2025

Offering Details

Type
Equity, Security to be Acquired
Exemptions
Rule 506(b)

Related Persons

NameRole
Isaac Stoner
Executive Officer, Director
Bradley Margus
Director
Christopher O'Donnell
Director
Reetika Bhardwaj
Director
Robert Nelson
Executive Officer

Company

MindImmune Therapeutics, Inc.

130 FLAGG ROAD

KINGSTON, RI, 02881

401-225-4612

SEC Filing

0001792522-25-000002

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free
MindImmune Therapeutics, Inc. Form D Filing — $12,000,000 | FilingFlow